COMP <GO>
CYPH vs UNH // PIOTROSKI F-SCORE QUALITY
Cypherpunk Technologies Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: CYPH 0
— UNH 7
▲ PIOTROSKI F-SCORE QUALITY LEADER: UNH
LAST: $3.31 (+2.16%) • MKT CAP: $356.7M
piotroski-score
3/9
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
piotroski-score
7/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CYPH VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CYPH | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 88.57% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -23.30% | 11.47% | -34.77 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -12.31% | 6.48% | -18.79 | UNH | /fcf-yield <GO> |
| Operating Margin | — | 4.82% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 3.14% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 6.46% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.12 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 3/9 | 7/9 | -4.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.0 | 59.2 | -8.24 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 66.3x | 17.1x | +49.21 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $356.7M | $368.83B | -$368.47B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CYPH REV | UNH REV | CYPH GROSS % | UNH GROSS % | CYPH FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $447.57B | — | 88.7% | -$43.9M | $16.07B |
| FY 2024 | $0 | $400.28B | — | 88.3% | -$60.3M | $20.70B |
| FY 2023 | $0 | $371.62B | — | 89.6% | -$43.8M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CYPH // BETA —
UNH // BETA 0.33